http://www.fpnotebook.com/
Susceptible Tuberculosis Treatment
Aka: Susceptible Tuberculosis Treatment, Susceptible Tb Treatment
- See Also
- Tuberculosis
- Latent Tuberculosis Treatment
- Active Tuberculosis Treatment
- Possibly Resistant Tuberculosis Treatment
- Multiple Drug Resistant Tuberculosis Treatment
- Indications
- Resistance rate in patient's Community <4%
- Most communities have Tb resistance >4%
- HIV Screening negative
- Immunocompetent
- No prior Tuberculosis Treatment
- Protocol: Overview (requires 2 phases of therapy)
- Initial phase: 3-4 drug regimen for 2 months
- Medications (4 used together in initial phase)
- Isoniazid and
- Rifampin and
- Pyrazinamide and
- Ethambutol (unless not indicated by culture)
- Dose timing
- Take once daily for 8 weeks (56 doses) or
- Take five times weekly for 8 weeks (40 doses)
- Given under direct observation
- Continuation phase: Double therapy for 4-7 months
- Medications (2 used together in continuation phase)
- Isoniazid and
- Rifampin
- Dose timing (18 weeks unless otherwise noted below)
- Once daily or
- Five times per week (direct observation)
- Duration of treatment
- Double therapy for 18 weeks unless exceptions below
- Indications for 7 month continuation phase
- Cavitary pulmonary Tuberculosis
- Positive Sputum Culture after initial phase
- Protocols
- CDC Division of Tuberculosis Elimination
- http://www.cdc.gov/nchstp/tb/
- References
- (2003) MMWR Morb Mortal Wkly Rep 52(RR-11):1